Phase II Study of FK949E -Placebo-controlled, Double-blind, Parallel-group Comparative Study in Major Depressive Disorder Patients With Lack of Response to Existing Antidepressants-
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Quetiapine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 25 Apr 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 08 Jul 2013 Planned end date changed from 1 May 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov record.